PREVENTICE SOLUTIONS AND BOSTON SCIENTIFIC SIGN ACQUISITION AGREEMENT
Today Boston Scientific announced it has entered into a definitive agreement to acquire Preventice Solutions, Inc.
The full press release can be found by visiting
https://news.bostonscientific.com/2021-01-21-Boston-Scientific-Announces-Agreement-To-Acquire-Preventice-Solutions-Inc
The company’s primary investors include Boston Scientific, Merck Global Health Innovation Fund, Vivo Capital and Novo Holdings A/S.
About Preventice Solutions
Preventice Solutions is a leading developer of mobile health solutions and remote monitoring services that connect patients threatened by cardiac
arrhythmias. Using insights to create revolutionary monitoring technologies, this tech-enabled, service-based approach can ultimately reduce the
cost of care and improve health outcomes. Preventice Solutions’ wearable portfolio includes the PatientCare Platform and BodyGuardian ® family.
